Back to 
State Street Corp.
State Street Corp.
BCLI
19 quarters
Position history for State Street Corp.'s holdings in BRAINSTORM CELL THERAPEUTICS
No. State Street exited its BCLI (Brainstorm Cell Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 117,260 shares worth $27,005. State Street first reported BCLI in Q2 2020 and held it in 18 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$4.7M
Total Shares Change
-422,678
Quarter-by-Quarter History
Other major holders of BCLI: Geode Capital Management, LLC, Invesco Ltd., Northern Trust Corp., Renaissance Technologies LLC